Compare Eaton Corporation plc (ETN) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Eaton (ETN) trades at $395.5, down 4.82% over 24 hours, but remains near its 52-week high. The stock shows a bullish technical trend with strong moving averages and support at $392. Fundamentally, the company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $2.81 exceeding the $2.73 estimate. Revenue for 2025 reached $27.45 billion, with a net income margin of 13.99%. Analyst sentiment is overwhelmingly positive, with a consensus price target of $449.50 and 64.1% of analysts rating it a Buy.

The outlook for ETN is favorable, driven by strong demand in data center power infrastructure and recent strategic acquisitions. However, risks include elevated valuation multiples like a P/E of 40.4 and potential macroeconomic pressures on industrial spending. The stock offers upside to the consensus target but requires monitoring of execution on growth initiatives and competitive dynamics in the power management sector.

Zimmer Biomet (ZBH) trades at $92.94, up 2.1% on the day, with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with a 70% gross margin and positive cash flow trends, though net income margin has declined from 13.8% in 2023 to 8.6% in 2025. Recent developments include expansion in Asia Pacific and a planned $1 billion share repurchase, indicating management confidence.

ZBH presents a moderate growth opportunity with a consensus price target of $97.67, offering ~5% upside. Risks include rising debt levels and competitive pressures in medical devices. Analyst sentiment is mixed with 40% buy ratings, but institutional activity and strategic acquisitions support a stable outlook for long-term investors.